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1. Background
Multidrug resistant (MDR) serotype 8 
pneumococci showing resistance to erythromycin, 
clindamycin, tetracyclines, and ciprofloxacin, 
have been detected since 2004 in Spain as cause of 
invasive disease in adult patients. 
2. Methods
Among 932 invasive serotype 8 pneumococci 
received at the Spanish Reference Laboratory in 
the 1997-2010 period, 113 (12.1%) were multidrug 
resistant. These MDR-serotype 8 isolates were 
typed by PFGE/MLST and PCR-RFLP analysis 
of PBPs 1A, 2B and 2X. Resistance genes (ermB, 
mefA/E and tetM) were detected by PCR. Changes 
in ParC, ParE and GyrA were studied by PCR-
RFLP analysis. Nucleotide sequencing of pbps and 
parC, parE and gyrA were performed. 
3. Results
The first MDR-serotype 8 was detected in 2004 
in Madrid, and then spread to other geographical 
areas. All MDR-serotype 8 were isolated from 
adults and most of  them were men (78.8%). 
MDR-serotype 8 isolates accounted for 20.2% 
of  invasive serotype 8 in 2004-2010 period. 
All MDR-serotype 8 isolates were genetically 
related to the Sweden15A-ST63 PMEN clone by 
PFGE and MLST (ST63), had identical PCR-
RFLP profiles of PBP, harbored ermB and tetM 
genes, and had a ParC-S79F change. Forty-six 
isolates having ciprofloxacin MIC —16 mg/L had 
additional GyrA changes (S81F or E85K). The 
sequence of pbp2x gene of the MDR-serotype 
8 clone was identical to those of the antibiotic 
susceptible ST53-serotype 8 isolates. Whereas 
pbp2b gene sequence of MDR-serotype 8 isolates 
was identical to those of Sweden15A-ST63 PMEN-
clone. One of  the recombinational points was 
found into the pbp1a gene. 
4. Conclusions
A fluorquinolone- and multidrug-resistant 
serotype8 clone (ST63) emerged in 2004 in Spain 
and spread over the country causing invasive 
disease in adults. A genetic interchange of both, 
pbp2x and capsular genes from a donor ST53-
isolate to a ST63 pneumococci could originate the 
recombinant serotype 8-ST63 clone.
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ABSTRACT: 
Fosfomycin targets the first step of peptidoglycan biosynthesis in Streptococcus pneumoniae 
catalyzed by UDP-N-acetylglucosamine enolpyruvyltransferase (MurA1). We investigated whether 
heteroresistance to fosfomycin occurs in S. pneumoniae. We found that of 11 strains tested all but 
one (Hungary19A) displayed heteroresistance.
Hungary19A differs from the other strains by a single amino acid substitution in MurA1 (Ala364Thr). 
To test whether this substitution confers structural changes leading to catalytic pocket modification 
high-resolution crystal structures of MurA1 in one representative heteroresistant strain (D39) and 
in the non-heteroresistant strain Hungary19A have been solved. We found no relevant structural 
differences between MurA1 of the two strains. Furthermore, the heteroresistant phenotype of 
strain D39 was not changed upon introduction of the amino acid substitution Ala364Thr by site-
directed mutagenesis indicating that, besides MurA1, another factor within the genome is involved 
in the heteroresistance phenotype.
Our results reveal that heteroresistance to fosfomycin is the predominant phenotype in S. 
pneumoniae due to the presence of MurA1 thus providing a caveat for any future use of fosfomycin 
in the treatment of pneumococcal infections.
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